Amaris Elliott Engel

August 25, 2014 | National Law Journal

The Food and Drug Administration has issued new guidance on labeling for pharmaceutical products and biologic products.

By Amaris Elliott-Engel

2 minute read

August 25, 2014 | National Law Journal

The U.S. Court of Appeals for the Fourth Circuit has ruled that five class actions in which plaintiffs allege that they have been deprived of royalty payments for the production of coalbed methane gas should not have been certified.

By Amaris Elliott-Engel

3 minute read

August 25, 2014 | National Law Journal

Lawyers who refiled a putative class action against a health insurer with new clients instead of appealing the loss of their first case escaped sanctions in federal district court. But they did not escape an upbraiding by the U.S. Court of Appeals for the Seventh Circuit.

By Amaris Elliott-Engel

3 minute read

August 21, 2014 | National Law Journal

The U.S. Court of Appeals for the Sixth Circuit has given a woman who lost part of her jaw another chance to prosecute a products liability case against Novartis Pharmaceuticals Corporation.

By Amaris Elliott-Engel

2 minute read

August 21, 2014 | National Law Journal

The tit-for-tat between an asbestos plaintiff and a defendant on whether a case should proceed in state court or federal court has ended in a ruling from the U.S. Court of Appeals for the Fourth Circuit that the case should move forward in Baltimore City Circuit Court.

By Amaris Elliott-Engel

2 minute read

August 21, 2014 | National Law Journal

In an issue of first impression, the U.S. Court of Appeals for the First Circuit has set out a test for the tax treatment of the millions of dollars dialysis chain Fresenius Medical Care Holdings, Inc. paid to the government to settle claims it violated the False Claims Act.

By Amaris Elliott-Engel

2 minute read

August 21, 2014 | National Law Journal

A group of pharmaceutical companies have moved to block the public records request made by USA Today to access documents disclosed as Chicago investigated claims about opioid painkillers.

By Amaris Elliott-Engel

2 minute read

August 21, 2014 | National Law Journal

A gasket-maker says that complying with a subpoena for information about asbestos claims asserted against it would not violate a protocol that has been established to allow people and companies to object to the unsealing of evidence of alleged misrepresentation by asbestos plaintiffs lawyers.

By Amaris Elliott-Engel

3 minute read

August 21, 2014 | National Law Journal

A putative class action of mariners took a “gamble” they would be entitled to more extensive rest and recuperation under American maritime law if they sued Carnival Corporation & PLC, a dual-listed company composed of a Panamanian corporation headquartered in Miami and a British corporation headquartered in Southampton, England, a federal appeals court said.

By Amaris Elliott-Engel

2 minute read

August 20, 2014 | National Law Journal

Providio MediSolutions LLC has been appointed to administer the $650 million settlement fund Boehringer Ingelheim GmbH agreed to over its blood-thinner Pradaxa.

By Amaris Elliott-Engel

2 minute read